Approvals/TGA/ENGERIX-B hepatitis B surface antigen recombinant (yeast) 20 microgram/1mL injection syringe

Approved

STANDARD

ENGERIX-B hepatitis B surface antigen recombinant (yeast) 20 microgram/1mL injection syringe

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 31cb13ad2940eb8a
Product Name: ENGERIX-B hepatitis B surface antigen recombinant (yeast) 20 microgram/1mL injection syringe
Artg Id: 123713
Artg Name: ENGERIX-B hepatitis B surface antigen recombinant (yeast) 20 microgram/1mL injection syringe
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 2006-07-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/3ba0b6875e31925b26777d55b4db2a51.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/be3a07ebb3d9ff7c2393abf8d9a4fbb0.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

31cb13ad2940eb8a

Type

Standard